Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1121

1.

Race and sex differences in the receipt of timely and appropriate lung cancer treatment.

Shugarman LR, Mack K, Sorbero ME, Tian H, Jain AK, Ashwood JS, Asch SM.

Med Care. 2009 Jul;47(7):774-81. doi: 10.1097/MLR.0b013e3181a393fe.

PMID:
19536007
2.

Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer.

Hardy D, Liu CC, Xia R, Cormier JN, Chan W, White A, Burau K, Du XL.

Cancer. 2009 May 15;115(10):2199-211. doi: 10.1002/cncr.24248.

3.

Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?

Keating NL, Kouri E, He Y, Weeks JC, Winer EP.

Med Care. 2009 Jul;47(7):765-73. doi: 10.1097/MLR.0b013e31819e1fe7.

PMID:
19536008
4.

Treatment and survival differences in older Medicare patients with lung cancer as compared with those who are dually eligible for Medicare and Medicaid.

Bradley CJ, Dahman B, Given CW.

J Clin Oncol. 2008 Nov 1;26(31):5067-73. doi: 10.1200/JCO.2008.16.3071. Epub 2008 Sep 15.

5.

Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.

Iezzoni LI, Ngo LH, Li D, Roetzheim RG, Drews RE, McCarthy EP.

Arch Phys Med Rehabil. 2008 Apr;89(4):595-601. doi: 10.1016/j.apmr.2007.09.042. Review.

PMID:
18373987
6.

Racial differences in the treatment of early-stage lung cancer.

Bach PB, Cramer LD, Warren JL, Begg CB.

N Engl J Med. 1999 Oct 14;341(16):1198-205.

7.

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.

Med Care. 2004 Mar;42(3):239-50.

PMID:
15076823
8.

Residual treatment disparities after oncology referral for rectal cancer.

Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD.

J Natl Cancer Inst. 2008 May 21;100(10):738-44. doi: 10.1093/jnci/djn145. Epub 2008 May 13.

9.

Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients.

Hardy D, Xia R, Liu CC, Cormier JN, Nurgalieva Z, Du XL.

Cancer. 2009 Oct 15;115(20):4807-18. doi: 10.1002/cncr.24521.

10.
11.

The effect of race on invasive staging and surgery in non-small-cell lung cancer.

Lathan CS, Neville BA, Earle CC.

J Clin Oncol. 2006 Jan 20;24(3):413-8. Epub 2005 Dec 19.

12.

Impact of referral patterns on the use of chemotherapy for lung cancer.

Earle CC, Neumann PJ, Gelber RD, Weinstein MC, Weeks JC.

J Clin Oncol. 2002 Apr 1;20(7):1786-92.

PMID:
11919235
13.

Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.

Murphy MM, Simons JP, Ng SC, McDade TP, Smith JK, Shah SA, Zhou Z, Earle CC, Tseng JF.

Ann Surg Oncol. 2009 Nov;16(11):2968-77. doi: 10.1245/s10434-009-0656-5. Epub 2009 Aug 11.

PMID:
19669839
14.

Population variations in the initial treatment of non-small-cell lung cancer.

Potosky AL, Saxman S, Wallace RB, Lynch CF.

J Clin Oncol. 2004 Aug 15;22(16):3261-8.

16.

Racial disparities in treatment and survival of male breast cancer.

Crew KD, Neugut AI, Wang X, Jacobson JS, Grann VR, Raptis G, Hershman DL.

J Clin Oncol. 2007 Mar 20;25(9):1089-98.

17.

Race and gender disparities in rates of cardiac revascularization: do they reflect appropriate use of procedures or problems in quality of care?

Epstein AM, Weissman JS, Schneider EC, Gatsonis C, Leape LL, Piana RN.

Med Care. 2003 Nov;41(11):1240-55.

PMID:
14583687
18.

Preferences for cardiac tests and procedures may partially explain sex but not race disparities.

Takakuwa KM, Shofer FS, Limkakeng AT Jr, Hollander JE.

Am J Emerg Med. 2008 Jun;26(5):545-50. doi: 10.1016/j.ajem.2007.08.020.

PMID:
18534282
19.

Differences in breast cancer stage, treatment, and survival by race and ethnicity.

Li CI, Malone KE, Daling JR.

Arch Intern Med. 2003 Jan 13;163(1):49-56.

PMID:
12523916
20.

Decrease in racial disparities in the staging evaluation for prostate cancer after publication of staging guidelines.

Abraham N, Wan F, Montagnet C, Wong YN, Armstrong K.

J Urol. 2007 Jul;178(1):82-7; discussion 87. Epub 2007 May 11.

PMID:
17499294
Items per page

Supplemental Content

Write to the Help Desk